Skip to main content

David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies

David J. Dykeman is interviewed on a podcast episode titled "David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies" for the Product Success Podcast: Quality and Medical Devices.

LINKS

Click here to listen to the podcast episode, "David Dykeman from Greenberg Traurig Advises on How a Strategic Patent Portfolio and Secure IP are key for Growth, Valuation and Positioning in the market for MedTech Companies."